Pricing

Oncologists and Cost Issues
Dr. Palmer touches base on the importance of oncologists and consideration of cost issues, and gives a sense of how this impacts the healthcare system.
Read Article

In April, the American Society of Clinical Oncology (ASCO) released a policy statement recommending how to fix the 340B Drug Pricing Program.
Read Article

US and Canadian medical oncologists share similar attitudes on the costs, cost-effectiveness, and health policies concerning new cancer drugs, despite fundamental differences between the 2 countries regarding how these drugs are covered and paid for under their respective healthcare systems.
Read Article

Page 2 of 2